论文部分内容阅读
自从发现白细胞介素Ⅱ(IL-2)后,人们开始探索在体外对淋巴样细胞进行长期培养和大量扩增,从而解决了以往难以得到的足够量抗肿瘤效应细胞,获得了肿瘤过继免疫治疗的新进展。1980年 Roserberg 等首先报
Since the discovery of interleukin II (IL-2), people have begun to explore the long-term culture and large-scale expansion of lymphoid cells in vitro, thus solving a sufficient amount of anti-tumor effect cells that were difficult to obtain in the past, and obtained tumor adoptive immunotherapy. New progress. 1980 first report by Roserberg et al.